With RF ablation of recurrent thyroid cancers, the mean volume reduction has been reported to be 56–93% [23, 26], and with 42–58% of the nodules disappearing completely [23–25], 64% of the patients experiencing symptom improvement [26], and with the serum thyroglobulin concentration decreasing [23–26]. This evidence concerns the gene TG and thyroid cancer.